Director Jim Fasano of IQVIA Holdings Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 154 deferred shares on November 5, 2026, under the company's Non-Employee Director Deferral Plan.
Jeffrey Raider, a director at Warby Parker, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 30,000 shares of Warby Parker common stock on NYSE under a Rule 10b5-1 plan.
Neil Blumenthal, a director and officer of Warby Parker Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 73,133 shares of Warby Parker common stock on the New York Stock Exchange.
Director Leslie Wims Morris of IQVIA Holdings Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 125 deferred shares on November 5, 2026, at a price of $264.88 per share under the company's Non-Employee Director Deferral …
David Gilboa, a director and officer of Warby Parker, Inc., filed a Form 144 notice of proposed sale on November 9, 2026, disclosing plans to sell 75,402 shares of common stock on the New York Stock Exchange.
Director John G. Danhakl filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 134 deferred shares of IQVIA Holdings Inc. common stock on November 5, 2026.
Director Colleen A. Goggins filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 144 deferred shares of IQVIA Holdings Inc. common stock on November 5, 2026.
IQVIA Holdings Inc. officer Eric Sherbet filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 4,446 shares of IQVIA common stock acquired through Stock Appreciation Rights, with an aggregate market value of $1,239,678.18.
Glenn J. Williams, Chief Executive Officer and Director of Primerica, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 1,500 shares of Primerica common stock under a Rule 10b5-1 plan.
Primerica Inc. director and officer Glenn J. Williams filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,500 shares of Primerica common stock with an aggregate market value of $435,870.00.